Misonix Reports First Quarter Fiscal Year 2009 Financi... ( Revenues Increased 7.4%; Net Inco...)

Misonix Reports First Quarter Fiscal Year 2009 Financial Results

Date:11/13/2008

Revenues Increased 7.4%; Net Income of $.05 per Diluted Share

FARMINGDALE, N.Y., Nov. 13 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today reported financial results for its fiscal year 2009 first quarter ended September 30, 2008. Michael A. McManus, Jr., President and Chief Executive Officer, and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call at 4:30 p.m. Eastern on Thursday, November 13, 2008 to discuss the Company's first quarter financial results.

-- Revenues increased 7.4% to $11.3 million

-- Reported net income of $320,000 or $.05 per diluted share

-- The Company reported the following operational achievements:

-- Entered a new, three year exclusive distribution agreement in Russia

for the Sonablate 500(R)

-- Received second FDA approval for the Sonablate 600(R) Soft Tissue

Ablation System

-- Entered a new two year exclusive distribution agreement in Czech

Republic for Sonastar(TM), SonicOne(R) and BoneScalpel(TM)

Revenues for the three months ended September 30, 2008 were $11.3 million, a 7.4% increase, when compared with revenues of $10.5 million for the same period in fiscal 2008. The increase is due to a $621,000 increase in sales of laboratory and scientific products to $5.9 million and a $154,000 increase in medical device products sales to $5.4 million. The increase in sales of medical device products is due to a $173,000 increase in therapeutic medical device products partially offset by a $1
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
2. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
3. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
4. Corgenix Reports Financial Results for First Quarter of Fiscal 2009
5. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
6. Spheris Reports Third Quarter 2008 Results
7. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
8. Symmetry Medical Reports Third Quarter 2008 Financial Results
9. EntreMed Reports Clinical Program Progress and Company Update
10. NBTY Reports Fourth Quarter and Fiscal Year Results
11. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results

Post Your Comments:

Misonix Reports First Quarter Fiscal Year 2009 Financi...( Revenues Increased 7.4%; Net Inco...),Health